Listening to NPR today, found out that some critical care injectable drugs are in very short supply. These are the expensive super new drugs, they are the old stand bys. Why? No profit.Some suppliers quit production, others just ignore maintaince issues untill the production stops.That should read not new super drugs.No one wants to invfest money in generic drug manufacture.



Reply With Quote